135
Views
48
CrossRef citations to date
0
Altmetric
Original Research

Quercetin nanoparticle complex attenuated diabetic nephropathy via regulating the expression level of ICAM-1 on endothelium

, , , , &
Pages 7799-7813 | Published online: 24 Oct 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Xian Chen, Wenni Dai, Hao Li, Zhe Yan, Zhiwen Liu & Liyu He. (2023) Targeted drug delivery strategy: a bridge to the therapy of diabetic kidney disease. Drug Delivery 30:1.
Read now
Lei Yan, Mostafa Vaghari-Tabari, Faezeh Malakoti, Soheila Moein, Durdi Qujeq, Bahman Yousefi & Zatollah Asemi. (2023) Quercetin: an effective polyphenol in alleviating diabetes and diabetic complications. Critical Reviews in Food Science and Nutrition 63:28, pages 9163-9186.
Read now
Jingwen Liu, Jiaoxian Cao, Yiming Li & Fujiang Guo. (2023) Beneficial Flavonoid in Foods and Anti-obesity Effect. Food Reviews International 39:1, pages 560-600.
Read now
Yasamin Davatgaran Taghipour, Marziyeh Hajialyani, Rozita Naseri, Mahvash Hesari, Pantea Mohammadi, Azzurra Stefanucci, Adriano Mollica, Mohammad Hosein Farzaei & Mohammad Abdollahi. (2019) Nanoformulations of natural products for management of metabolic syndrome. International Journal of Nanomedicine 14, pages 5303-5321.
Read now
Krishnendu Manna, Snehasis Mishra, Moumita Saha, Supratim Mahapatra, Chirag Saha, Govind Yenge, Nilesh Gaikwad, Ramkrishna Pal, Dasharath Oulkar, Kaushik Banerjee & Krishna Das Saha. (2019) Amelioration of diabetic nephropathy using pomegranate peel extract-stabilized gold nanoparticles: assessment of NF-κB and Nrf2 signaling system. International Journal of Nanomedicine 14, pages 1753-1777.
Read now
Fei Tong, Suhuan Liu, Bing Yan, Xuejun Li, Shiwei Ruan & Shuyu Yang. (2018) Endogenous ornithine decarboxylase/polyamine system mediated the antagonist role of insulin/PEG-CMCS preconditioning against heart ischemia/reperfusion injury in diabetes mellitus. International Journal of Nanomedicine 13, pages 2507-2520.
Read now

Articles from other publishers (42)

Amin Bagheri, Ghazal Radman, Negar Aria, Fatemeh Rezaei, Mohammad Khajenouri, Shamim Ghiabi & Yasin Bagheri. (2023) The Effects of Quercetin on Apoptosis and Antioxidant Activity in a Renal Ischemia/Reperfusion Injury Animal Model. Drug Research 73:05, pages 255-262.
Crossref
Qichao Hu, Lan Jiang, Qi Yan, Jinhao Zeng, Xiao Ma & Yanling Zhao. (2023) A natural products solution to diabetic nephropathy therapy. Pharmacology & Therapeutics 241, pages 108314.
Crossref
Selvaraj Kunjiappan, Theivendren Panneerselvam, Sureshbabu Ram Kumar Pandian, Parasuraman Pavadai, Saravanan Govindaraj, Vigneshwaran Ravishankar, Sankarganesh Arunachalam & Sankaranarayanan Murugesan. 2023. Emerging Nanotechnologies for Medical Applications. Emerging Nanotechnologies for Medical Applications 95 130 .
Yi-Qin Chen, Hao-Yin Chen, Qin-Qi Tang, Yi-Fan Li, Xu-Sheng Liu, Fu-Hua Lu & Yue-Yu Gu. (2022) Protective effect of quercetin on kidney diseases: From chemistry to herbal medicines. Frontiers in Pharmacology 13.
Crossref
Ipargul Hafiz, Zhezhe Li, Zhaozhi Wang, Hongji He, Xiaohui Tang & Mei Wang. (2022) Improving the antitumor efficiency against hepatocellular carcinoma by harmine-loaded liposomes with mitochondria targeting and legumain response. Journal of Drug Delivery Science and Technology 75, pages 103623.
Crossref
Ponnurengam Malliappan Sivakumar, Pranav Kumar Prabhakar, Sibel Cetinel, Neelakandan R. & Veluchamy Prabhawathi. (2022) Molecular Insights on the Therapeutic Effect of Selected Flavonoids on Diabetic Neuropathy. Mini-Reviews in Medicinal Chemistry 22:14, pages 1828-1846.
Crossref
Subhajit Maity, Arghya Acharyya & Abhay Sankar Chakraborti. (2022) Flavonoid-based polymeric nanoparticles: A promising approach for cancer and diabetes treatment. European Polymer Journal 177, pages 111455.
Crossref
Neera Yadav, Amit Kumar Tripathi & Amna Parveen. (2022) PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression. Pharmaceutics 14:7, pages 1326.
Crossref
Tingyan Hu, Junlun Yue, Qiuwen Tang, Ka-Wing Cheng, Feng Chen, Mijun Peng, Qian Zhou & Mingfu Wang. (2022) The effect of quercetin on diabetic nephropathy (DN): a systematic review and meta-analysis of animal studies. Food & Function 13:9, pages 4789-4803.
Crossref
Íris Guerreiro, Cíntia Ferreira-Pêgo, Diogo Carregosa, Cláudia N. Santos, Regina Menezes, Ana S. Fernandes & João G. Costa. (2022) Polyphenols and Their Metabolites in Renal Diseases: An Overview. Foods 11:7, pages 1060.
Crossref
Xiao Feng, Fan Bu, Liguo Huang, Weilong Xu, Wenbin Wang & Quan Wu. (2022) Preclinical evidence of the effect of quercetin on diabetic nephropathy: A meta-analysis of animal studies. European Journal of Pharmacology 921, pages 174868.
Crossref
Halil Sezgin Semis, Cihan Gur, Mustafa Ileriturk, Fatih Mehmet Kandemir & Ozgur Kaynar. (2021) Evaluation of Therapeutic Effects of Quercetin Against Achilles Tendinopathy in Rats via Oxidative Stress, Inflammation, Apoptosis, Autophagy, and Metalloproteinases. The American Journal of Sports Medicine 50:2, pages 486-498.
Crossref
Akurange Sujeevi Dammadinna Wickramasinghe, Pabasara Kalansuriya & Anoja Priyadarshani Attanayake. (2022) Nanoformulation of Plant-Based Natural Products for Type 2 Diabetes Mellitus: From Formulation Design to Therapeutic Applications. Current Therapeutic Research 96, pages 100672.
Crossref
Çiğdem Yücel & Gökçe Şeker Karatoprak. 2022. The Role of Phytonutrients in Metabolic Disorders. The Role of Phytonutrients in Metabolic Disorders 67 102 .
Roberta Jeane Bezerra Jorge, Aline Diogo Marinho, João Alison de Moraes Silveira, Márcia Maria Vieira Ramos, Jacqueline Ramos Machado Braga, Renata de Sousa Alves, Francisco Assis Nogueira-Junior, Mirele da Silveira Vasconcelos, Ana Sanches Silva, Seyed Mohammad Nabavi & Dirce Fernandes de Melo. 2022. Antioxidants Effects in Health. Antioxidants Effects in Health 755 798 .
Biswanath Dinda & Subhajit Dinda. 2022. Natural Products in Obesity and Diabetes. Natural Products in Obesity and Diabetes 507 532 .
Yuntao Liu, Siqi Zeng, Wei Ji, Huan Yao, Lin Lin, Haiying Cui, Hélder A. Santos & Guoqing Pan. (2021) Emerging Theranostic Nanomaterials in Diabetes and Its Complications. Advanced Science 9:3.
Crossref
Hanaa H. Ahmed, Soheir E. Kotob, Ahmed A. Abd-Rabou, Hadeer A. Aglan & Gamal A. Elmegeed. (2021) Pre-Clinical Evidence for the Anti-Obesity Potential of Quercetin and Curcumin Loaded Chitosan/PEG Blended PLGA Nanoparticles. Biomedical and Pharmacology Journal 14:4, pages 1731-1759.
Crossref
Qichao Hu, Caiyan Qu, Xiaolin Xiao, Wenwen Zhang, Yinxiao Jiang, Zhao Wu, Dan Song, Xi Peng, Xiao Ma & YanLing Zhao. (2021) Flavonoids on diabetic nephropathy: advances and therapeutic opportunities. Chinese Medicine 16:1.
Crossref
Santwana Padhi, Monalisa Dash & Anindita Behera. (2021) Nanophytochemicals for the treatment of type II diabetes mellitus: a review. Environmental Chemistry Letters 19:6, pages 4349-4373.
Crossref
Huan Xu, Tianyi Wu & Leaf Huang. (2021) Therapeutic and delivery strategies of phytoconstituents for renal fibrosis. Advanced Drug Delivery Reviews 177, pages 113911.
Crossref
Gaoxiang Wang, Lin Zeng, Qian Huang, Zhaoqi Lu, Ruiqing Sui, Deliang Liu, Hua Zeng, Xuemei Liu, Shufang Chu, Xinhui Kou & Huilin Li. (2021) Exploring the Molecular Mechanism of Liuwei Dihuang Pills for Treating Diabetic Nephropathy by Combined Network Pharmacology and Molecular Docking. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-14.
Crossref
Sónia Rocha, Mariana Lucas, Daniela Ribeiro, M. Luísa Corvo, Eduarda Fernandes & Marisa Freitas. (2021) Nano-based drug delivery systems used as vehicles to enhance polyphenols therapeutic effect for diabetes mellitus treatment. Pharmacological Research 169, pages 105604.
Crossref
Hansen Yang, Zheng Zhang, Rui Peng, Luyu Zhang, Handeng Liu, Xinyi Wang, Yiting Tian & Yan Sun. (2021) RNA-Seq analysis reveals critical transcriptome changes caused by sodium butyrate in DN mouse models. Bioscience Reports 41:4.
Crossref
Olina Dagher, Pauline Mury, Nathalie Thorin-Trescases, Pierre Emmanuel Noly, Eric Thorin & Michel Carrier. (2021) Therapeutic Potential of Quercetin to Alleviate Endothelial Dysfunction in Age-Related Cardiovascular Diseases. Frontiers in Cardiovascular Medicine 8.
Crossref
Shan Lu, Shuai Zhou, Juwu Chen, Jian Zheng, Jia Ren, Peiyi Qi, Zhiqiang Zhu & Zhenzhen Li. (2021) Quercetin Nanoparticle Ameliorates Lipopolysaccharide-Triggered Renal Inflammatory Impairment by Regulation of Sirt1/NF-KB Pathway. Journal of Biomedical Nanotechnology 17:2, pages 230-241.
Crossref
Weie Zhou, Xuefeng Zhou, Yuan Zhang, Yuyang Wang, Wenjie Wu, Haojun Zhang, Tingting Zhao, Liang Peng, Hailing Zhao & Ping Li. (2021) A Network Pharmacology-Based Approach for Exploring Key Active Compounds and Pharmacological Mechanisms of Tangshen Formula for Treatment of Diabetic Nephropathy. Journal of Diabetes Research 2021, pages 1-17.
Crossref
Shengfeng Wan, Shengkai Wan, Xiaojing Jiao, Huixia Cao, Yue Gu, Lei Yan, Yan Zheng, Peiyuan Niu & Fengmin Shao. (2021) Advances in understanding the innate immune‐associated diabetic kidney disease. The FASEB Journal 35:2.
Crossref
Yuenan Zheng, Xuan Shi, Jiebin Hou, Songyan Gao, Yufan Chao, Jiarong Ding, Long Chen, Yong Qian, Guojian Shao, Yachen Si & Wei Chen. (2021) Integrating metabolomics and network pharmacology to explore Rhizoma Coptidis extracts against sepsis-associated acute kidney injury. Journal of Chromatography B 1164, pages 122525.
Crossref
Ehsan Dehdashtian, Mohammad Hossein Pourhanifeh, Karim Hemati, Saeed Mehrzadi & Azam Hosseinzadeh. (2020) Therapeutic application of nutraceuticals in diabetic nephropathy: Current evidence and future implications. Diabetes/Metabolism Research and Reviews 36:8.
Crossref
Amitabha Acharya & Vikram Patial. (2020) Nanotechnological interventions for the treatment of renal diseases: Current scenario and future prospects. Journal of Drug Delivery Science and Technology 59, pages 101917.
Crossref
Zeynep Goktas, Yujiao Zu, Mehrnaz Abbasi, Shannon Galyean, Dayong Wu, Zhaoyang Fan & Shu Wang. (2020) Recent Advances in Nanoencapsulation of Phytochemicals to Combat Obesity and Its Comorbidities. Journal of Agricultural and Food Chemistry 68:31, pages 8119-8131.
Crossref
Theresa F. Rambaran. (2020) Nanopolyphenols: a review of their encapsulation and anti-diabetic effects. SN Applied Sciences 2:8.
Crossref
Fatemeh Oroojalian, Fahimeh Charbgoo, Maryam Hashemi, Amir Amani, Rezvan Yazdian-Robati, Ahad Mokhtarzadeh, Mohammad Ramezani & Michael R. Hamblin. (2020) Recent advances in nanotechnology-based drug delivery systems for the kidney. Journal of Controlled Release 321, pages 442-462.
Crossref
Lixia Tang, Ke Li, Yan Zhang, Huifang Li, Ankang Li, Yuancheng Xu & Bing Wei. (2020) Quercetin liposomes ameliorate streptozotocin-induced diabetic nephropathy in diabetic rats. Scientific Reports 10:1.
Crossref
Emil Jivishov, Lutfun Nahar & Satyajit D. Sarker. 2020. Medicinal Natural Products: A Disease-Focused Approach. Medicinal Natural Products: A Disease-Focused Approach 251 271 .
Biswanath Dinda, Manikarna Dinda, Arup Roy & Subhajit Dinda. 2020. Inflammatory Disorders - Part B. Inflammatory Disorders - Part B 159 235 .
Subhamoy Banerjee. 2020. Plant-derived Bioactives. Plant-derived Bioactives 591 619 .
Habib Yaribeygi, Luis E. Simental‐Mendía, Alexandra E. Butler & Amirhossein Sahebkar. (2018) Protective effects of plant‐derived natural products on renal complications. Journal of Cellular Physiology 234:8, pages 12161-12172.
Crossref
Massimo Dal Monte, Maurizio Cammalleri, Valeria Pecci, Monica Carmosino, Giuseppe Procino, Alessandro Pini, Mario De Rosa, Vincenzo Pavone, Maria Svelto & Paola Bagnoli. (2019) Inhibiting the urokinase-type plasminogen activator receptor system recovers STZ-induced diabetic nephropathy. Journal of Cellular and Molecular Medicine 23:2, pages 1034-1049.
Crossref
Junlin Zhang, Yiting Wang, Rui Zhang, Hanyu Li, Qianqian Han, Yucheng Wu, Shanshan Wang, Ruikun Guo, Tingli Wang, Li Li & Fang Liu. (2018) Serum fibrinogen predicts diabetic ESRD in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 141, pages 1-9.
Crossref
Y. Chen, L. Zhao, S. Jiang, Z. Hu, B. Hu, F. Tong & R. Shen. (2018) Cystathionine γ-Lyase Is Involved in the Renoprotective Effect of Brief and Repeated Ischemic Postconditioning After Renal Ischemia/Reperfusion Injury in Diabetes Mellitus. Transplantation Proceedings 50:5, pages 1549-1557.
Crossref